Literature DB >> 27694899

APOBEC3A associates with human papillomavirus genome integration in oropharyngeal cancers.

S Kondo1, K Wakae2, N Wakisaka1, Y Nakanishi1, K Ishikawa1, T Komori1, M Moriyama-Kita1, K Endo1, S Murono1, Z Wang2,3, K Kitamura2, T Nishiyama4, K Yamaguchi5, S Shigenobu5, M Muramatsu2, T Yoshizaki1.   

Abstract

The prevalence of human papillomavirus (HPV)-related oropharyngeal cancers has been increasing in developed countries. We recently demonstrated that members of the apolipoprotein B mRNA-editing catalytic polypeptide 3 (APOBEC3, A3) family, which are antiviral factors, can induce hypermutation of HPV DNA in vitro. In the present study, we found numerous C-to-T and G-to-A hypermutations in the HPV16 genome in oropharyngeal cancer (OPC) biopsy samples using differential DNA denaturation PCR and next-generation sequencing. A3s were more abundantly expressed in HPV16-positive OPCs than in HPV-negative, as assessed using immunohistochemistry and reverse transcription quantitative PCR. In addition, interferons upregulated A3s in an HPV16-positive OPC cell line. Furthermore, quantitative PCR analysis of HPV DNA suggests that APOBEC3A (A3A) expression is strongly correlated with the integration of HPV DNA. These results suggest that HPV16 infection may upregulate A3A expression, thereby increasing the chance of viral DNA integration. The role of A3A in HPV-induced carcinogenesis is discussed.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27694899     DOI: 10.1038/onc.2016.335

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  51 in total

1.  Dual effect of APOBEC3G on Hepatitis B virus.

Authors:  Chiemi Noguchi; Nobuhiko Hiraga; Nami Mori; Masataka Tsuge; Michio Imamura; Shoichi Takahashi; Yoshifumi Fujimoto; Hidenori Ochi; Hiromi Abe; Toshiro Maekawa; Hiromi Yatsuji; Kotaro Shirakawa; Akifumi Takaori-Kondo; Kazuaki Chayama
Journal:  J Gen Virol       Date:  2007-02       Impact factor: 3.891

2.  Rapid and sensitive detection of physical status of human papillomavirus type 16 DNA by quantitative real-time PCR.

Authors:  Shoji Nagao; Mitsuo Yoshinouchi; Yasunari Miyagi; Atsushi Hongo; Junichi Kodama; Sachio Itoh; Takafumi Kudo
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

3.  Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck.

Authors:  J Mork; A K Lie; E Glattre; G Hallmans; E Jellum; P Koskela; B Møller; E Pukkala; J T Schiller; L Youngman; M Lehtinen; J Dillner
Journal:  N Engl J Med       Date:  2001-04-12       Impact factor: 91.245

4.  Human papillomavirus and rising oropharyngeal cancer incidence in the United States.

Authors:  Anil K Chaturvedi; Eric A Engels; Ruth M Pfeiffer; Brenda Y Hernandez; Weihong Xiao; Esther Kim; Bo Jiang; Marc T Goodman; Maria Sibug-Saber; Wendy Cozen; Lihua Liu; Charles F Lynch; Nicolas Wentzensen; Richard C Jordan; Sean Altekruse; William F Anderson; Philip S Rosenberg; Maura L Gillison
Journal:  J Clin Oncol       Date:  2011-10-03       Impact factor: 44.544

5.  APOBEC3B is an enzymatic source of mutation in breast cancer.

Authors:  Michael B Burns; Lela Lackey; Michael A Carpenter; Anurag Rathore; Allison M Land; Brandon Leonard; Eric W Refsland; Delshanee Kotandeniya; Natalia Tretyakova; Jason B Nikas; Douglas Yee; Nuri A Temiz; Duncan E Donohue; Rebecca M McDougle; William L Brown; Emily K Law; Reuben S Harris
Journal:  Nature       Date:  2013-02-06       Impact factor: 49.962

6.  RNA editing of hepatitis B virus transcripts by activation-induced cytidine deaminase.

Authors:  Guoxin Liang; Kouichi Kitamura; Zhe Wang; Guangyan Liu; Sajeda Chowdhury; Weixin Fu; Miki Koura; Kousho Wakae; Tasuku Honjo; Masamichi Muramatsu
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-22       Impact factor: 11.205

7.  Defining APOBEC3 expression patterns in human tissues and hematopoietic cell subsets.

Authors:  Fransje A Koning; Edmund N C Newman; Eun-Young Kim; Kevin J Kunstman; Steven M Wolinsky; Michael H Malim
Journal:  J Virol       Date:  2009-07-08       Impact factor: 5.103

8.  Uracil DNA glycosylase counteracts APOBEC3G-induced hypermutation of hepatitis B viral genomes: excision repair of covalently closed circular DNA.

Authors:  Kouichi Kitamura; Zhe Wang; Sajeda Chowdhury; Miyuki Simadu; Miki Koura; Masamichi Muramatsu
Journal:  PLoS Pathog       Date:  2013-05-16       Impact factor: 6.823

9.  In vivo and in vitro studies suggest a possible involvement of HPV infection in the early stage of breast carcinogenesis via APOBEC3B induction.

Authors:  Kenji Ohba; Koji Ichiyama; Misako Yajima; Nobuhiro Gemma; Masaru Nikaido; Qingqing Wu; PeiPei Chong; Seiichiro Mori; Rain Yamamoto; John Eu Li Wong; Naoki Yamamoto
Journal:  PLoS One       Date:  2014-05-23       Impact factor: 3.240

Review 10.  HIV-1 Vif, APOBEC, and intrinsic immunity.

Authors:  Ritu Goila-Gaur; Klaus Strebel
Journal:  Retrovirology       Date:  2008-06-24       Impact factor: 4.602

View more
  23 in total

1.  Activation of DNA damage repair factors in HPV positive oropharyngeal cancers.

Authors:  Takeyuki Kono; Paul Hoover; Kate Poropatich; Tatjana Paunesku; Bharat B Mittal; Sandeep Samant; Laimonis A Laimins
Journal:  Virology       Date:  2020-05-22       Impact factor: 3.616

2.  PYHIN genes as potential biomarkers for prognosis of human papillomavirus-positive or -negative head and neck squamous cell carcinomas.

Authors:  Giuseppe Riva; Giancarlo Pecorari; Matteo Biolatti; Sara Pautasso; Irene Lo Cigno; Massimiliano Garzaro; Valentina Dell'Oste; Santo Landolfo
Journal:  Mol Biol Rep       Date:  2019-04-12       Impact factor: 2.316

Review 3.  The case for BK polyomavirus as a cause of bladder cancer.

Authors:  Gabriel J Starrett; Christopher B Buck
Journal:  Curr Opin Virol       Date:  2019-07-20       Impact factor: 7.090

4.  APOBEC3A regulates transcription from interferon-stimulated response elements.

Authors:  Manabu Taura; John A Frank; Takehiro Takahashi; Yong Kong; Eriko Kudo; Eric Song; Maria Tokuyama; Akiko Iwasaki
Journal:  Proc Natl Acad Sci U S A       Date:  2022-05-12       Impact factor: 12.779

Review 5.  Pathogenic Role of Immune Evasion and Integration of Human Papillomavirus in Oropharyngeal Cancer.

Authors:  Takashi Hatano; Daisuke Sano; Hideaki Takahashi; Nobuhiko Oridate
Journal:  Microorganisms       Date:  2021-04-21

Review 6.  Roles of APOBEC3A and APOBEC3B in Human Papillomavirus Infection and Disease Progression.

Authors:  Cody J Warren; Joseph A Westrich; Koenraad Van Doorslaer; Dohun Pyeon
Journal:  Viruses       Date:  2017-08-21       Impact factor: 5.048

7.  The curious case of APOBEC3 activation by cancer-associated human papillomaviruses.

Authors:  Nicholas A Wallace; Karl Münger
Journal:  PLoS Pathog       Date:  2018-01-11       Impact factor: 6.823

8.  Biologic and behavioral associations of estrogen receptor alpha positivity in head and neck squamous cell carcinoma.

Authors:  Virginia Drake; Elaine Bigelow; Carole Fakhry; Melina Windon; Lisa M Rooper; Patrick Ha; Brett Miles; Christine Gourin; Rajarsi Mandal; Wojciech Mydlarz; Nyall London; Peter S Vosler; Siddhartha Yavvari; Tanya Troy; Tim Waterboer; David W Eisele; Gypsyamber D'Souza
Journal:  Oral Oncol       Date:  2021-07-22       Impact factor: 5.972

9.  HPV11 E6 mutation by overexpression of APOBEC3A and effects of interferon-ω on APOBEC3s and HPV11 E6 expression in HPV11.HaCaT cells.

Authors:  Yongfang Wang; Xinyu Li; Shasha Song; Yang Sun; Jiafen Zhang; Changming Yu; Wei Chen
Journal:  Virol J       Date:  2017-11-03       Impact factor: 4.099

10.  Expression and subcellular localisation of AID and APOBEC3 in adenoid and palatine tonsils.

Authors:  Noriko Seishima; Satoru Kondo; Kousho Wakae; Naohiro Wakisaka; Eiji Kobayashi; Makoto Kano; Makiko Moriyama-Kita; Yosuke Nakanishi; Kazuhira Endo; Tomoko Imoto; Kazuya Ishikawa; Hisashi Sugimoto; Miyako Hatano; Takayoshi Ueno; Miki Koura; Koichi Kitamura; Masamichi Muramatsu; Tomokazu Yoshizaki
Journal:  Sci Rep       Date:  2018-01-17       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.